Theriva Corp (TOVX): Average Forecast Price

The development of anti-tumor modified adenoviruses by Theriva Biologics, Inc. (TOVX) relies on strict patent protection and the availability of sophisticated laboratories. Anticipation of trial results for pancreatic treatment drugs at the current price of 4.02 serves as the primary driver. The status of a preclinical startup implies a lack of profit and high capital expenditure. This chart of the TOVX price trend clearly demonstrates the market dynamics of this biotech project.

Theriva Biologics Inc - TOVX Consensus Target (period 04/28/2023 - 11/15/2026)

Metric breakdowns and analytics for Theriva Biologics (TOVX)

- stock quotes and analyst forecast:

Price Theriva Biologics Inc|TOVX - Price Target Chart

- stock exchange capitalization data:

Market Value Theriva Biologics, Inc.|TOVX - Real Price to Acquire Entire Company

- shareholders' equity book value data:

Net Assets per Single Share Theriva Biologics|TOVX - Company Net Assets|Capitalization to Book Value Ratio therivabio.com|TOVX - Aggregate Company Assets

- business debt structure and liquidity details:

- financial results and valuation multiples details:

TOVX - Company Net Income|Expected Net Profit Theriva Biologics, Inc.|TOVX - P/E Multiple|Forward Price to Earnings Multiple Theriva Biologics, Inc.|TOVX - Price/Earnings to Growth Multiple|Company Value to EBITDA Theriva Biologics, Inc.|TOVX - Operating profit before deduction of amortization|Earnings per share for the trailing year Theriva Biologics|TOVX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months therivabio.com|TOVX - Earnings per share growth in current year|Expected earnings per share growth for next year Theriva Biologics, Inc.

- sales revenue and business income indicators:

TOVX - Company Revenue|Company Future Sales Volume Synthetic Biologics|TOVX - Market Cap to Revenue|Forward P/S Multiple Theriva Biologics|TOVX - Sales Growth YoY (Last Twelve Months)

General company analysis:TOVX (Theriva Biologics Inc)

This metric synthesizes weighted average target values from industry experts, filtering out market noise to identify the long-term vector of fundamental value. By analyzing the analysts' consensus price target, an investor can see how the market is pricing in risks for Theriva Biologics, Inc. (TOVX) related to clinical trial uncertainty and capital shortages amid fierce competition in the biopharmaceutical sector.

Competitors of Theriva Biologics, Inc.